Anatomic Pathology Testing Market

Anatomic Pathology Testing Market -
Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2017 - 2025
Transparency Market Research Reports incorporated a definite
business overview and investigation inclines on "Anatomic
Pathology Testing Market". This report likewise incorporates
more illumination about fundamental review of the business
including definitions, requisitions and worldwide business sector
industry structure.
Anatomic pathology is a branch of science or branch of
medicine that primarily involves microscopic, biochemical, and
molecular examination of organs and tissues to find out the
effectiveness of diseases. The key objective of anatomic
pathology is to identify abnormalities in order to manage
diagnosis and treatment. Anatomic pathology helps to detect
various types of tumor and cancer. It is also sometimes useful to
evaluate the liver and kidney diseases effectively.
Gross examination, histopathology, immunohistochemistry,
cytopathology, and flow immunophenotyping are some of the
procedures carried out during anatomic pathology test. Anatomic
pathology testing is a superspeciality test. To perform this type
of test, a person should have a qualified certification from a
recognized body such as the American Board of Pathology or
the American Osteopathic Board of Pathology. Anatomic

pathologist is also involved in post mortem examination. Like
clinical pathology reports, anatomic pathology reports also
contain essential elements such as name, number, sample type,
and source. Many anatomic pathology departments operate
according to the specific need of a patient.
Browse Full Research Report on Anatomic Pathology
Testing Market:
http://www.transparencymarketresearch.com/anatomic-pathologytesting-market.html
The anatomic pathology testing market has been segmented
based on product, services, and application. In terms of product,
the market has been categorized into instruments and
consumables. Instruments such as microscope, centrifuges,
slides, and cassette printers are used to conduct anatomic
pathology tests. Consumables include kits, reagents, and
antibodies. Based on services, the anatomic pathology testing
market has been segmented into cytopathology and
histopathology. In terms of application, the market has been
categorized into breast cancer diagnosis, lung cancer diagnosis,
and cervical cancer diagnosis.
Based on end-user, the global anatomic pathology testing market
has been segmented into clinical diagnostic laboratories,
hospitals, and physician office laboratories. Increasing
prevalence of chronic diseases, maximum use of biomarkers,

direct to customer facility, and government awareness about
early cancer detection and diagnosis are likely to boost the
growth of the anatomic pathology testing market. High cost of
digital imaging, poor resolution, set up costs, lack of depth
perception are some of the factors restraining the market.
Geographically, the anatomic pathology testing market is
dominated by North America due to rising incidence of cancer
and epathology solutions. Rising prevalence of chronic diseases,
rapid increase in geriatric population, and high acceptance of
personalized medicine and digital laboratory propel the market
in Europe. Growing academic and government investment in
diagnostic research and rising awareness about the use of
anatomic pathology test among physicians are projected to boost
the growth of the market in Asia Pacific.
Increasing globalization, sound economy, and changing lifestyle
habits of the population in the region has led to the growth of the
anatomy pathology testing market in Latin America. High life
expectancy, increasing burden of diseases, increasing chronic
and non-communicable diseases such as diabetes, cancer, and
obesity fuel the growth of the anatomic pathology testing
market. Improving living standards, and increasing demand for

quality medicines in Middle East & Africa boost the growth of
the anatomy pathology testing market in the region.
Major players in the anatomic pathology testing market are
Abbott Diagnostic International Ltd., Agilent Technologies,
Danaher, Roche Diagnostics, Bio SB, Neogenomics
Laboratories, Inc., and Quest Diagnostics Incorporated.
About Us
Transparency Market Research (TMR) is a global market
intelligence company providing business information reports
and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop
distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com